Cannabinoid quinone derivatives
AssigneeVivacell Biotechnology Espana, S.L.
InventorsEduardo Muñoz Blanco, Giovanni Appendino, María Luz Bellido Cabello De Alba
Life of this patent
Estimating the term…
Abstract
Cannabinoid quinone derivatives. The present invention refers to cannabinoid quinone derivatives to be used as medicaments, particularly as PPAR gamma (PPARg) agonists for treating diseases which etiology is based on an impaired PPARg function as transcription factor i.e. PPARg-related diseases.
Claims9
-14. (canceled)
Compound characterized by having the formula (VI) or derivatives thereof:
Method for treating PPARg-related diseases that comprises the administration to the patient of an effective amount of a pharmaceutical composition comprising a compound of Formula (VI) or derivatives thereof:
Dependencies are inferred from the claim text.